Procurement of Lassa Fever Medicines and Medical Consumables for Infection Prevention... Tender

Procurement Summary

Country : Nigeria

Summary : Procurement of Lassa Fever Medicines and Medical Consumables for Infection Prevention and Control for Human Health Sector

Deadline : 22 Jul 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 68148393

Document Ref. No. : GDS-RFB-01-2022

Financier : World Bank (WB)

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Tenders are invited for Procurement of Lassa Fever Medicines and Medical Consumables for Infection Prevention and Control for Human Health Sector
1 Medicines for Lassa Fever treatment
2 Medicines for post exposure prophylaxis
3 Medicines for Cholera and Meningitis
4 General Personnel Protective Equipment (PPE)
5 Medical consumables for infection and prevention
6 Medial consumables for investigation

Bid security: At least 3% of Bid price
Bidding will be conducted through, open, National competitive Procurement using a request for Bids (RFB) as specified in the World Bank-s “Procurement Regulations for IPF Borrowers” July 2016, revised November 1, 2017 and August 1, 2018 and is open to all eligible bidders as defined in the procurement Regulation.

Interested bidders may obtain further information from the Nigerian Centre for Disease Control, Regional Disease Surveillance Systems Enhancement Project (REDISSE II), Mr. Marcel N, D-A, Email: marel.dibang@ncdc.gon.ng and inspect the biding document during office hours from 0900 to 1700 hours local time at the address give below. Qualification requirements include:
• Documentary evidence of two contracts of similar nature and magnitude during the last five (50 years
• Valid and up to date certifications with FIRS (tax Clearance), NSITF, PENCOM, ITF & BPP
• Audited financial statement for the last three (3) years i.e. 2019, 2020 & 2021 to demonstrate the financial capability of the Bidder in terms of profitability and adequate working capital.
• A manufacturer-s Authorization/NAFDAC registration certificate that has NAFDAC number for Ribavirin not produced by the company. Additional details are provided in the bidding documents.

Documents

 Tender Notice